Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Merck

Pharma company funding for patient advocacy groups needs to be transparent

Patient groups should be playing a central role in Canada’s health-care system, advocating for their members by promoting the visibility of their conditions, pushing for more rapid and accurate diagnoses and lobbying for the introduction and funding of new treatments and drugs that may help relieve their members’ symptoms and…

The Conversation

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

The Conversation

Eighty-eight Corporate Leaders Endorse Harris For Continued 'Strength' Of Democracy, Economy

Letter signers include Yelp, Snap and Box CEOs, media empire heir James Murdoch, former CEOs of PepsiCo, Lyft and Merck

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Merck & Co. Stock: Is MRK Underperforming the Healthcare Sector?

Merck & Co. has underperformed the healthcare sector this year, but Wall Street analysts are bullish about the stock prospects.

Barchart

3 Healthcare Stocks Positioned for Major Gains in 2024

With advancements in biomedical sciences and promising drug pipelines, the healthcare industry is set for substantial growth in the coming years. Hence, investors might find opportunities in adding UnitedHealth Group (UNH), Merck & Co. (MRK), and Pfizer (PFE) to their portfolios for potential gains this year. Read on….

StockNews.com

Is It Time to Buy These Overlooked Dividend Stocks?

These defensive healthcare picks from the Dow Jones Industrial Average are worth a look at current levels for investors seeking passive income.

Barchart

Merck & Co. Stock: Analyst Estimates & Ratings

Despite Merck & Co.’s relative underperformance over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Vaccines tell a success story that Robert F. Kennedy Jr. and Trump forget – here are some key reminders

Vaccinations have provided significant protection for the public against infectious diseases. However, there was a modest decrease in support in 2023 nationwide for vaccine requirements for children to attend public schools.

The Conversation

Wall Street Billionaire Investors Dumped Nvidia Shares in Q1, Bought These Three Stocks Instead

Nvidia continues to innovate AI GPUs and maintains a strong balance sheet, but hedge fund managers see several headwinds for the company in the coming months.

International Business Times UK

Akira Endo obituary

Japanese biochemist whose work on fungal extracts led to the creation of the first statin

The Guardian - UK

3 Dow Dividend Stocks Beating the Market This Year

While all eyes are still on standout AI tech stocks, these three dividend-paying Dow stocks are beating the broader market this year.

Barchart

Is Merck & Company Stock Outperforming the Dow

Merck & Company has significantly outperformed the Dow Jones recently, and Wall Street analysts expect further gains for the stock.

Barchart

Do Wall Street Analysts Like Merck & Company Stock?

As Merck outperforms the broader market this year, Wall Street analysts remain optimistic about the stock's prospects.

Barchart

The Fight Against Cancer Enters a New Phase

Breakthrough treatments hold promise for patients and investors.

Kiplinger

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

5 Standout Healthcare Dividend Stocks to Consider Now

Amid healthcare’s enduring importance and increasing demand for its products and services, here are five dividend-paying healthcare stocks to consider now.

StockNews.com

Merck (MRK) vs. AbbVie (ABBV): Which Pharma Stock Will Drive Earnings Growth?

The pharmaceutical industry is expected to expand significantly due to the ever-rising global medical needs and technological advances. In this scenario, let’s analyze the better investment option between popular pharma stocks, Merck &Co (MRK) and AbbVie (ABBV).

StockNews.com

4 Pharma Giants Sparking Investor Interest

The pharmaceutical industry is growing steadily, focusing more on technological innovation, precision medicine, and strategic mergers and acquisitions (M&A). So, let’s take a look at pharma giants Novo Nordisk A/S (NVO), Johnson & Johnson (JNJ), Merck & Co. (MRK), and AbbVie (ABBV) igniting investor interest. Keep reading….

StockNews.com

Aurora Cannabis (ACB) vs. Merck (MRK): Which Pharma Stock Holds Greater Potential for Investors?

The pharmaceutical industry is poised for robust growth owing to technological advancements and growing healthcare needs. Given this backdrop, let’s analyze Aurora Cannabis (ACB) and Merck & Co. (MRK) to determine which of the two stocks holds greater potential for investors. Read on….

Get all your
news in one place.

100’s of premium titles.
One news app.

Top News

European Shares Open Higher After Mixed Trading Session In Asia

European shares rise, S&P 500 hits record high, dollar strengthens, Asian markets mixed. Market anticipates U.S. government's update on consumer spending a...

Kiplinger

Stock Market Today: Dow Outperforms as Merck Hits New High

The S&P 500 and Dow Jones Industrial Average snapped three-day losing streaks as drugmaker Merck rallied.

The Hindu

NASA touts space research in anti-cancer fight

Cancer research in space began more than 40 years ago but has become “revolutionary” in recent years, said Mr. Nelson, a former Democratic senator who traveled into space himself in 1986.

StockNews.com

3 Pharma Stocks Fueling Investor Enthusiasm

The pharmaceutical industry is expected to expand rapidly due to growing global healthcare needs and advancements in technology. Therefore, fundamentally strong pharma stocks Merck (MRK), AbbVie (ABBV), and GSK plc (GSK) might be ideal additions to your portfolio. Read on.

Barchart

3 Cheap Dividend Stocks to Scoop Up This March

After a second straight losing week for stocks, investors in search of relative safety in the market might want to consider value-priced dividend stocks - like the three income picks we've highlighted here.

Barchart

Stocks Close Mildly Lower on Caution Ahead of Tuesday’s U.S. CPI Report

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed -0.37%. Stocks Monday traded mildly lower on a +2.3 bp rise in the 10-year T-note...

International Business Times

Women Battle On For Equality In Top Business Jobs

More women are taking top management jobs but inequality persists, with men still dominating business leadership roles, research showed ahead of International Women's Day on March 8.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.